"Designing Growth Strategies is in our DNA"

U.S. Mycoplasma Testing Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments and Reagents & Kits), By Testing Method (PCR-based, Culture-based, and Others), By Application (Cell Culture, Vaccine Testing, Virus Testing, and Others), and By End-user (Biopharmaceutical & Biotechnology Companies, Cell Banks, Contract Research & Contract Manufacturing Organizations, and Others), and Country Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108747

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Overview of R&D Expenditure, U.S., 2022
    2. Technological Advancements in Mycoplasma Testing
    3. Key Industry Developments – Mergers, Acquisitions & Partnership
    4. New Product Launches
    5. Impact of COVID-19 on the Market
  5. U.S. Mycoplasma Testing Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Testing Method
      1. PCR-based
      2. Culture-based
      3. Others
    2. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    3. Market Analysis, Insights and Forecast – By Application
      1. Cell Culture
      2. Vaccine Testing
      3. Virus Testing
      4. Others
    4. Market Analysis, Insights and Forecast – By End User
      1. Biopharmaceutical & Biotechnology Companies
      2. Cell banks
      3. Contract Research Organizations & Contract Manufacturing Organizations
      4. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Merck KGaA
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Thermo Fisher Scientific Inc.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Sartorius AG
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Asahi Kasei Corporation
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. BIOMÉRIEUX
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Charles River Laboratories
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. ATCC
        1. Overview
        2. Product
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Other Prominent Players
Read Less

Figure 1:  U.S. Mycoplasma Testing Market Revenue Breakdown (USD million, %) by Testing Method, 2022 & 2030

Figure 2: U.S. Mycoplasma Testing Market Value Share (%), by Testing Method, 2022 & 2030

Figure 3:  U.S. Mycoplasma Testing Market Value Share (%), by Product, 2022 & 2030

Figure 4:  U.S. Mycoplasma Testing Market Value Share (%), by Application, 2022 & 2030

Figure 5:  U.S. Mycoplasma Testing Market Value Share (%), by End User, 2022 & 2030

Figure 6:  U.S. Mycoplasma Testing Market Share (%), By Company, 2022

Table 1:  U.S. Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2019-2030

Table 2:  U.S. Mycoplasma Testing Market Revenue (USD million) Forecast, by Product, 2019-2030

Table 3:  U.S. Mycoplasma Testing Market Revenue (USD million) Forecast, Application, 2019-2030

Table 4:  U.S. Mycoplasma Testing Market Revenue (USD million) Forecast, End User, 2019-2030

U.S. Mycoplasma Testing Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann